bluebird bio (BLUE) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for bluebird bio (BLUE) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$5.870B||$0.006B|
|Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.|